162 related articles for article (PubMed ID: 3012290)
1. Genomic and antigenic comparison of an equine herpesvirus 1 (EHV 1) isolate from the 1983 Lippizan abortion storm with EHV 1 reference strains.
Engels M; Nowotny N; Metzler AE; Wyler R; Bürki F
Microbiologica; 1986 Apr; 9(2):221-34. PubMed ID: 3012290
[TBL] [Abstract][Full Text] [Related]
2. A new field strain of equine abortion virus (equine herpesvirus-1) among Kentucky horses.
Allen GP; Yeargan MR; Turtinen LW; Bryans JT
Am J Vet Res; 1985 Jan; 46(1):138-40. PubMed ID: 2982294
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
4. Isolation and comparative restriction endonuclease DNA fingerprinting of equine herpesvirus-1 from cattle.
Crandell RA; Ichimura H; Kit S
Am J Vet Res; 1988 Nov; 49(11):1807-13. PubMed ID: 2854705
[TBL] [Abstract][Full Text] [Related]
5. [The polymerase chain reaction (PCR) for the detection of DNA of equine herpesviruses 1 and 4].
Hardt M; Teifke JP; Weiss E
Berl Munch Tierarztl Wochenschr; 1992 Feb; 105(2):52-5. PubMed ID: 1313672
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
[TBL] [Abstract][Full Text] [Related]
7. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
8. Molecular confirmation of an abortigenic strain of equine herpesvirus 1 (subtype 1) in a pregnant mare study.
Martens JG; Martens RJ; Crandell RA; McConnell S; Kit S
Cornell Vet; 1989 Oct; 79(4):363-71. PubMed ID: 2548809
[TBL] [Abstract][Full Text] [Related]
9. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
10. Detection of equine herpesvirus 1 genome 1B in Argentina.
Martínez JP; Martín Ocampos GP; Fernandez LC; Fuentealba NA; Cid de la Paz V; Barrandeguy M; Galosi CM
Rev Sci Tech; 2006 Dec; 25(3):1075-9. PubMed ID: 17361771
[TBL] [Abstract][Full Text] [Related]
11. One way protection between equid herpesvirus 1 and 4 in vivo.
Edington N; Bridges CG
Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
[TBL] [Abstract][Full Text] [Related]
13. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
15. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California.
Pusterla N; Wilson WD; Mapes S; Finno C; Isbell D; Arthur RM; Ferraro GL
Vet J; 2009 Feb; 179(2):230-9. PubMed ID: 18024200
[TBL] [Abstract][Full Text] [Related]
16. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
17. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
18. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
Bürki F; Nowotny N; Hofer A
Dtsch Tierarztl Wochenschr; 1991 Mar; 98(3):82-9. PubMed ID: 1646100
[TBL] [Abstract][Full Text] [Related]
19. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
20. Monitoring and detection of acute viral respiratory tract disease in horses.
Mumford EL; Traub-Dargatz JL; Salman MD; Collins JK; Getzy DM; Carman J
J Am Vet Med Assoc; 1998 Aug; 213(3):385-90. PubMed ID: 9702229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
